4.7 Article

Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate

Journal

BLOOD
Volume 113, Issue 8, Pages 1856-1859

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-03-145789

Keywords

-

Categories

Funding

  1. CIRM fellowship (San Francisco, CA)
  2. NIH
  3. Margaret Early Foundation Award (Los Angeles, CA)
  4. American Heart Society (Burlin-game, CA)
  5. Concern Foundation (Beverly Hills, CA)
  6. American Cancer Society (Atlanta, GA)
  7. March of Dimes Foundation (White Plains, NY)
  8. NIH/NHLBI (National Heart, Lung, and Blood Institute) [1R21HL082643-01]

Ask authors/readers for more resources

Specification of endothelial cell (EC) fate during vascular development is controlled by distinct key regulators. While Notch plays an essential role in induction of arterial phenotypes, COUP-TFII is required to maintain the venous EC identity. Homeodomain transcription factor Prox1 functions to reprogram venous ECs to lymphatic endothelial cells (LECs). Here, we report that the venous EC fate regulator COUP-TFII is expressed in LECs throughout development and physically interacts with Prox1 to form a stable complex in various cell types including LECs. We found that COUP-TFII functions as a coregulator of Prox1 to control several lineage-specific genes including VEGFR-3, FGFR-3, and neuropilin-1 and is required along with Prox1 to maintain LEC phenotype. Together, we propose that the physical and functional interactions of the 2 proteins constitute an essential part in the program specifying LEC fate and may provide the molecular basis for the hypothesis of venous EC identity being the prerequisite for LEC specification. (Blood. 2009;113:1856-1859)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available